Journal Logo

Published Ahead-of-Print - Last Updated: May 27, 2020

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.


PDF Only


Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib

Vidarsdottir, Linda; Fernandes, Rita Valador; Zachariadis, Vasilios; More

Melanoma Research. ., Post Author Corrections: May 27, 2020

Survival estimation of melanoma patients with brain metastasis using the Melanoma-molGPA score: external validation from a French cohort

Dalmasso, Céline; Pagès, Cécile; Chaltiel, Léonor; More

Melanoma Research. ., Post Author Corrections: May 11, 2020

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

Vera Aguilera, Jesus; Paludo, Jonas; McWilliams, Robert R.; More

Melanoma Research. ., Post Author Corrections: May 11, 2020

MC1R variants and cutaneous melanoma risk according to histological type, body site, and Breslow thickness: a pooled analysis from the M-SKIP project

Caini, Saverio; Gandini, Sara; Botta, Francesca; More

Melanoma Research. ., Post Author Corrections: May 03, 2020

Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases

Holtkamp, Lodewijka H.J.; Chakera, Annette H.; Fung, Sebastian; More

Melanoma Research. ., Post Author Corrections: May 03, 2020

BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma

Cybulska-Stopa, Bozena; Rogala, Pawel; Czarnecka, Anna M.; More

Melanoma Research. ., Post Author Corrections: March 25, 2020

The prognostic role of BRAF and WNT pathways activation in kinase inhibitors-naïve clinical stage III cutaneous melanoma

Kowalik, Artur; Jurkowska, Monika; Mierzejewska, Ewa; More

Melanoma Research. ., Post Author Corrections: February 17, 2020


PDF Only


Distinguishing melanophages from tumor in melanoma patients treated with talimogene laherparepvec

Audrey-Bayan, Claire; Trager, Megan H.; Gartrell-Corrado, Robyn D.; More

Melanoma Research. ., Post Author Corrections: April 22, 2020


PDF Only


Show: